Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic

Jie Zheng1, Yuemiao Zhang2, Humaira Rasheed1,3

  • 1MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, UK.

Insights

This study used Mendelian randomization to identify causal risk factors for chronic kidney disease (CKD). Eight factors, including BMI and hypertension, were causally linked to CKD in Europeans, while three were identified in East Asians.

Area of Science:

  • Genetics
  • Epidemiology
  • Nephrology

Background:

  • Chronic kidney disease (CKD) is a significant global health concern.
  • Identifying causal risk factors is crucial for effective prevention and treatment strategies.
  • Previous studies suggested several risk factors, but causal relationships require robust validation.

Purpose of the Study:

  • To systematically investigate the causal relationships between reported risk factors and CKD.
  • To differentiate causal links across European and East Asian ancestries.
  • To inform the development of targeted interventions for CKD prevention.

Main Methods:

  • Mendelian randomization analysis was employed to assess causality.
  • Genetic data from large cohorts of European (n=51,672 cases, 958,102 controls) and East Asian (n=13,093 cases, 238,118 controls) ancestries were utilized.
  • CKD was defined by clinical diagnosis or estimated glomerular filtration rate <60 ml/min/1.73 m².

Main Results:

  • Eight risk factors demonstrated causal effects on CKD in Europeans: body mass index (BMI), hypertension, systolic blood pressure, high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein(a), type 2 diabetes (T2D), and nephrolithiasis.
  • In East Asians, genetically predicted BMI, T2D, and nephrolithiasis showed causal links to CKD.
  • Hypertension showed a causal effect in Europeans but not in East Asians. A threshold effect of BMI on CKD risk was observed at BMI >25 kg/m².

Conclusions:

  • Several cardiometabolic risk factors, including BMI, hypertension, and T2D, have a causal impact on CKD development.
  • Ancestry-specific differences in causal risk factors for CKD were observed.
  • Findings provide evidence for prioritizing interventions targeting these causal factors to reduce CKD burden.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
11
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
70
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
105
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.6K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
97
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
315